Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesEndocrinologyblue cross blue shield - kansas growth hormone Pri…
    Ask Trek AI about this page
    Currentblue cross blue shield - kansasPolicy N/A

    Growth Hormone Prior Authorization Request

    Customize your policy alerts

    Sign up for all blue cross blue shield - kansas policy alerts

    Know when blue cross blue shield - kansas releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    A prior authorization request form and instructions for growth hormone therapy for BCBS Kansas members, detailing required documentation, clinical information for initial and renewal requests, and administrative submission instructions. It specifies required tests (growth hormone stimulation testing), documentation of diagnosis and growth data, and requirement to trial preferred product.

    Policy Summary
    Payerblue cross blue shield - kansas
    PolicyGrowth Hormone Prior Authorization Request
    Policy CodePolicy N/A
    Change TypeAdministrative form / coverage with criteria
    Effective Date
    Next Review Date
    Key ActionPrescriber must complete and sign the Growth Hormone Prior Authorization Request form and attach required documentation and submit via fax, email, or mail to BCBSKS Prior Authorization.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes — brief indicates this is a prior authorization form and instructions; has_material_change=false.

    1Preferred product trial required
    Adults:1/Children:2

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    GH stimulation tests
    Labs/Imaging/ChartsDocumentation required

    Coverage Summary

    This is the BCBSKS Growth Hormone Prior Authorization Request form (physician fax form). Coverage is covered with criteria and requires submission of the completed prescriber form and all required documentation. Required tests include growth hormone stimulation testing ( Adults: 1 stim test; Children: 2 stim tests). Approval also requires trial and failure of the BCBSKS Preferred Product before coverage of a non-preferred growth hormone.

    Quick thresholds & headline metrics
    Growth Hormone Stim TestsAdults: 1 stim test required; Children: 2 stim tests required
    Preferred product trialApproval requires trial and failure of the BCBSKS preferred agent
    Documentation types requiredAttach labs (IGF-1, TSH, FSH/LH, ACTH), imaging, growth charts, stim test results
    Prescriber/completion requirementOnly the prescriber may complete and sign the form; include NPI and signature
    Renewal demonstrationFor renewals, provide start date and evidence of clinical improvement and current growth rate

    Prior Authorization Requirements & Clinical Criteria

    General Prior Authorization Requirements

    Approval requires submission of all required documentation and trial/failure of preferred agent when applicable.

    • Prescriber section: Completed prescriber section (only prescriber may complete form) including prescriber name, specialty, NPI, signature, and contact information

      Source: Section 2 and header note

    • Patient demographics and insurance: Patient demographic and insurance information including copy of front/back of insurance card if possible

      Source: Section 1

    • Product selection and preferred agent trial: Specify product: BCBSKS Preferred Product or Other Growth Hormone; approval requires trial and failure of the preferred agent if Other Growth Hormone is requested

      Source: Section 1

    Provider Actions & Submission Instructions

    Prior Authorization

    Submit completed prior authorization form

    Prescriber must complete and sign the Growth Hormone Prior Authorization Request form and attach required documentation (labs, stim test results, growth charts, imaging, insurance card copies) and submit via fax, email, or mail to Blue Cross and Blue Shield of Kansas Prior Authorization.

    • Only the prescriber may complete and sign the form
    • Attach supporting documentation: labs, stimulation test results, growth charts, imaging, copy of front/back of insurance card
    • Submit completed form via Fax, Email, or Mail to BCBSKS Prior Authorization
    Documentation Required

    Attach stimulation test results

    Attach growth hormone stimulation test results. Adults require one stimulation test; children require two. Include the agents used and the peak values for each test.

    Background

    This document is a faxable prior authorization form used to request coverage for growth hormone therapy. Only the prescriber may complete the form. Administrative and clinical documentation required for initial and renewal requests must be attached, including patient demographics, copy of front/back of insurance card when possible, prescriber information and signature, the Rx/order details, and designation of pharmacy (Accredo or other).

    Clinical documentation required includes growth charts/curves, imaging studies, bone age and associated dates, height and percentile information, mid-parental height, growth rates, and relevant laboratory tests (IGF-1, TSH, FSH/LH, ACTH) for adults. Growth hormone stimulation testing is required for all patients—attach stim test results listing agents used and peak values: Adults: 1 stim test; Children: 2 stim tests.

    Renewal requests must indicate the date therapy started and demonstrate clinical improvement since initiation; if improvement occurred, indicate whether improvement has been maintained for one year or longer and provide current growth rate. The form also asks about open epiphyses status and whether complicating factors (eg, malnutrition, acidosis) are present and treated.

    Submit the completed form and attachments via fax, email, or mail to Blue Cross and Blue Shield of Kansas Prior Authorization as listed on the form.

    Open epiphyses: clinical status indicating growth plates are not yet closed (form asks Yes/No).

    Coding

    No specific CPT, HCPCS, or NDC codes are provided in the brief or on the form. Coding should follow the submitted prescription and dispensing pharmacy guidance when completing claims or requests.

    Revision History

    statusLatest

    No dated revisions provided; policy current.

    Policy Summary
    Payerblue cross blue shield - kansas
    PolicyGrowth Hormone Prior Authorization Request
    Policy CodePolicy N/A
    Change TypeAdministrative form / coverage with criteria
    Effective Date
    Next Review Date
    Key ActionPrescriber must complete and sign the Growth Hormone Prior Authorization Request form and attach required documentation and submit via fax, email, or mail to BCBSKS Prior Authorization.
    SourceLink
    On This Page
    Coverage SummaryPrior Authorization Requirements & Clinical CriteriaProvider Actions & Submission InstructionsBackgroundCodingRevision History
  1. Indicate renewal status: Indicate whether request is renewal and if renewal provide date therapy started

    Source: Section 1

  2. Rx order details: Provide Rx order details: form, strength/dose, quantity, refills, directions/frequency, ancillary supplies needed per injection; indicate pharmacy (Accredo or other)

    Source: Section 1 and Section 2

  3. Attachments - chart information: Attach relevant chart information (growth curves, imaging studies, stim tests, growth charts)

    Source: Section 2

  4. Open epiphyses: For children: document open epiphyses status (Yes/No)

    Source: Section 2

  5. Complicating factors: Document presence and treatment status of complicating factors (including malnutrition and acidosis) and whether treated if present

    Source: Section 2

  6. Childhood-onset confirmation: Document whether childhood-onset GHD was confirmed by testing during childhood (Yes/No)

    Source: Section 2

  7. Imaging: Document imaging demonstrating hypothalamic or pituitary disease/injury if applicable (Yes/No)

    Source: Section 2

  8. Growth and bone age data: Provide bone age, date measured, patient age when measured, height at diagnosis (cm), percentile of normal height, mid-parental height, growth rate (cm/yr) at diagnosis, and current growth rate for renewals

    Source: Section 2

  9. Laboratory results for adults: Attach copies of relevant laboratory results (IGF-1, TSH, FSH/LH, ACTH) for adults as applicable

    Source: Section 5

  10. Growth hormone stimulation testing required: one stim test for adults; two stim tests for children. Attach stim test results including agents used and peak valuesAdults: 1 stim test; Children: 2 stim tests

    Source: Section 5

  11. Renewal Criteria

    Renewal requests must demonstrate ongoing benefit and maintenance of improvement.

    • Renewal identification and therapy start date: Indicate renewal and date therapy started

      Source: Section 2

    • Demonstrated clinical improvement: Demonstrate that growth hormone therapy resulted in demonstrated clinical improvement since initiation of therapy

      Source: Section 2

    • Maintenance of improvement: If improvement occurred, indicate whether improvement has continued for or been maintained for one year or longer>=1 year if maintained

      Source: Section 2

    • Current growth rate: Provide current growth rate

      Source: Section 2

    • Adults: 1 stimulation test required
    • Children: 2 stimulation tests required
    • Include agent(s) used and peak values for each test
    Documentation Required

    Attach lab and growth documentation

    Attach relevant laboratory and growth documentation. For adults include IGF-1, TSH, FSH/LH, ACTH lab results. Include growth curves, bone age (with date and patient age when measured), height at diagnosis (cm), percentiles, mid-parental height, and growth rate information.

    • Attach lab results: IGF-1, TSH, FSH/LH, ACTH (adults)
    • Include growth curves and bone age with date and patient age when measured
    • Provide height at diagnosis (cm), percentile of normal height, mid-parental height, growth rate (cm/yr) at diagnosis, and current growth rate for renewals
    Step Therapy

    Preferred product trial required

    Approval requires a trial and documented failure of the BCBSKS preferred growth hormone agent before coverage will be provided for a non-preferred growth hormone.

    • Indicate product selection: BCBSKS Preferred Product or Other Growth Hormone
    • Note: Approval requires trial and failure of the preferred agent
    Billing Rule

    Pharmacy designation

    Specify the pharmacy to be used: select the preferred pharmacy (Accredo) or Other and include pharmacy contact information when indicated.

    • Preferred pharmacy: Accredo — Phone: 833-721-1620, Fax: 888-302-1028
    • Or indicate Other pharmacy and provide contact details